Daniel K. Spiegelman

Companies

• Maze Therapeutics, Inc.Board member Jan 30, 2025 to now¹
• vTv Therapeutics Inc.Board member Jun 13, 2024 to now²
• Kyverna Therapeutics, Inc.Board member Feb 7, 2024 to now³
• SPRUCE BIOSCIENCES, INC.Board member Oct 8, 2020 to now⁴
• Myriad GeneticsBoard member May 28, 2020 to Jun 7, 2024⁵
• Jiya Acquisition Corp.Board member Nov 18, 2020 to Nov 18, 2020⁶
• BioMarin PharmaceuticalChief financial officer May 29, 2012 to Jun 7, 2019⁷
• Anthera PharmaceuticalsBoard member Feb 23, 2010 to Jun 16, 2014⁸
• OMEROS CORPBoard member Dec 9, 2009 to Jun 4, 2012⁹
• CyclacelBoard member Jul 11, 2006 to May 24, 2012¹⁰

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Myriad Genetics MYGN32,917 shares¹¹$136.8K at $4.16Jun 7, 2024
• KTKyverna Therapeutics, Inc. KYTX16,634 shares¹²$96.6K at $5.80May 29, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• May 29, 2025Granted 16,634 shares of Kyverna Therapeutics, Inc.¹²
• Jun 4, 2024Sold 3,788 shares at $22.05 of Myriad Genetics¹³
• Jun 3, 2024Sold 3,788 shares at $22.04 of Myriad Genetics¹³
• Jun 2, 2023Sold 8,638 shares at $23.01 of Myriad Genetics¹⁴
• Jun 1, 2023Granted 15,151 shares of Myriad Genetics¹⁴
• Jun 6, 2022Sold 6,424 shares at $19.25 of Myriad Genetics¹⁵
• Jun 2, 2022Granted 17,275 shares of Myriad Genetics¹⁶